Patients with chronic kidney disease and Type 2 diabetes who took the experimental drug finerenone were about 30% less likely to develop the heart rhythm disorder atrial fibrillation (AFib) than those taking a placebo, according ...
May 17, 2021
0
2
Dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, did not significantly reduce the risk of organ failure or death or improve recovery in patients hospitalized with COVID-19 who are at high risk of developing ...
May 17, 2021
0
3
Heart failure (HF) - when the heart can't pump enough blood and oxygen through the body—affects approximately 6.2 million adults in the United States and is the primary cause of hospitalization in the elderly. Unfortunately, ...
May 16, 2021
0
2
(HealthDay)—Farxiga (dapagliflozin) oral tablets are now approved for adults with chronic kidney disease at risk for disease progression, the U.S. Food and Drug Administration announced Friday.
May 4, 2021
0
9
Although bronchopulmonary dysplasia (BPD)—a chronic lung disease affecting newborns—is the most common complication of preterm birth, it remains difficult to diagnose and treat. Researchers from Fundación INFANT in Buenos ...
Apr 27, 2021
0
7
The number of patients with heart failure worldwide nearly doubled from 33.5 million in 1990 to 64.3 million in 2017. That's the finding of a study published today in the European Journal of Preventive Cardiology, a journal ...
Feb 12, 2021
2
86
Medical histories of patients collected and stored in electronic health records (EHR) can be rapidly leveraged to predict the probability of death from COVID-19, information that could prove valuable in managing limited therapeutic ...
Feb 4, 2021
0
5
Cardiovascular disease is the leading cause of death in patients with type 2 diabetes, and youth with severe obesity and type 2 diabetes face a high risk of developing cardiovascular disease during their lifetime. However, ...
Dec 10, 2020
0
2
An analysis of Geisinger's electronic health records has revealed chronic kidney disease to be the leading risk factor for hospitalization from COVID-19.
Dec 2, 2020
0
12
Women face a 20% increased risk of developing heart failure or dying within five years after their first severe heart attack compared with men, according to new research published today in the American Heart Association's ...
Nov 30, 2020
1
32
